IL1B and breast cancer: The results indicate a significant P-value in the investigation of the relationship between IL-1β and ER + BC risk (OR 1.15, 95% CI 1.03–1.27, P = 0.0088) (Table 1), however, it is supported by only one SNP, and there are not enough SNPs to conduct assessment of heterogeneity and horizontal pleiotropy.